CEL-SCI has been one of Geneos Therapeutics's top competitors. CEL-SCI was founded in 1983, and is headquartered in Vienna, Virginia. CEL-SCI competes in the Biotechnology industry. CEL-SCI generates $2.4M less revenue vs. Geneos Therapeutics.
NexImmune is a top competitor of Geneos Therapeutics. NexImmune is a Public company that was founded in Gaithersburg, Maryland in 2011. Like Geneos Therapeutics, NexImmune also competes in the Biotechnology industry. NexImmune has 24 fewer employees vs. Geneos Therapeutics.